Baylor Genetics

Baylor Genetics is the commercial clinical genetics and genomics laboratory brand associated with Baylor College of Medicine, a medical and research institution based in Houston, Texas. The brand was established to consolidate and market the institution's long-standing clinical genetic testing activity — work that grew out of Baylor's genetics research and diagnostic laboratories — as a distinct, customer-facing laboratory service for hospitals, physicians, genetic counselors and patients. The brand's offering centers on clinical genetic and genomic testing: chromosomal microarray analysis, karyotyping and cytogenetics, single-gene and gene-panel sequencing, exome and genome sequencing, prenatal and reproductive genetics testing, carrier screening, and biochemical and metabolic testing, supported by genetic counseling and result-interpretation services. Its customers are primarily clinicians and health systems in the United States, and the brand is positioned as an academic medical-center laboratory — emphasizing clinical validity, board-certified laboratory leadership and research-backed test development rather than consumer-facing direct-to-consumer genetics. Ownership sits with Baylor College of Medicine, a private, nonprofit academic medical institution; Baylor Genetics is therefore a subsidiary/sub-brand rather than an independently listed company. Its positioning in the market is as a specialist reference laboratory competing with other academic and commercial genetics laboratories, differentiated by its academic parentage and breadth of rare-disease and prenatal testing menus. Note: the supplied evidence snippets do not contain material about Baylor Genetics; they concern unrelated Chinese financial-market research reports. The dossier below is therefore limited to well-established public facts about the brand, and no figures, dates or URLs beyond those are asserted.

Baylor Genetics traces its origins to the genetics research and clinical laboratory activity of Baylor College of Medicine in Houston, Texas, an institution with a long record in human and medical genetics. Over decades, Baylor's genetics laboratories developed diagnostic testing capabilities in cytogenetics, molecular genetics and biochemical genetics, and served as a reference point for clinicians seeking expert interpretation of complex genetic results. As clinical genomics expanded — particularly with chromosomal microarray analysis and later exome and genome sequencing — the institution moved to organize its testing operations under a dedicated commercial laboratory identity, Baylor Genetics, so that referring physicians and hospitals could access the tests through a single, clearly branded service organization. The brand has since been presented as the clinical genetics laboratory of Baylor College of Medicine, combining academic test development with a service-oriented laboratory operation. The laboratory's menu broadened over time to cover prenatal and reproductive genetics, pediatric and rare-disease diagnostics, carrier screening, and specialized biochemical and metabolic testing, alongside genetic counseling support. It operates as a subsidiary of the nonprofit Baylor College of Medicine rather than as an independent public company, and it competes in the U.S. reference-laboratory market with other academic and commercial genetics laboratories. No specific dated milestones, financial figures or executive names are asserted here because the supplied evidence does not cover this brand.

Academic medical-center reference laboratory specializing in clinical genetic and genomic diagnostics for clinicians and health systems.

• Chromosomal microarray analysis (CMA)

  Genome-wide copy-number analysis used in pediatric, prenatal and developmental diagnostics.

• Clinical exome and genome sequencing

  Sequencing-based testing for rare and undiagnosed genetic disease.

• Prenatal and reproductive genetic testing

  Testing supporting prenatal diagnosis and reproductive planning.

• Carrier screening

  Screening for recessive conditions relevant to family planning.

• Biochemical and metabolic testing

  Laboratory testing for inherited metabolic disorders.

• 2026

  Baylor Genetics notifies patients after data breach exposing IVF-related genetic testing data

  Baylor Genetics disclosed that an unauthorized third party accessed portions of its network between June 11 and June 17, and a review completed July 30 found that patient and employee information may have been exposed, including laboratory test results, health insurance data, and Social Security numbers for some individuals. The company sent letters this week to potentially affected patients, including people who underwent or are undergoing IVF, warning them of heightened phishing and fraud risks.

  Source

• 2026

  Edelson Lechtzin LLP investigates Baylor Genetics data breach claims

  Edelson Lechtzin LLP announced that it is investigating data privacy claims and a potential class action arising from a Baylor Genetics cybersecurity incident. According to the announcement, an unauthorized third party accessed portions of Baylor Genetics' network between June 11 and June 17, 2026, exposing patient and employee personal and health information. The firm's announcement concerns the investigation of claims related to the incident; no further details on the incident or its resolution are provided in the source.

  Source

Read more

1. 1Baylor Genetics notifies patients after data breach exposing IVF-related genetic testing datanewsweek.com
2. 2Edelson Lechtzin LLP investigates Baylor Genetics data breach claimsprnewswire.com